UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of hepatitis E in liver transplant recipients in Greece

Epidemiology and infection, 2018-10, Vol.146 (13), p.1619-1621

2018

Volltextzugriff (PDF)

Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease

Acta gastro-enterologica belgica, 2022-04, Vol.85 (2), p.331-337

2022

Volltextzugriff (PDF)

Urine Albumin-To-Creatinine Ratio is Associated with the Severity of Liver Disease, Renal Function and Survival in Patients with Decompensated Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S259-S260

2016

Volltextzugriff (PDF)

Comparison of Creatinine and Cystatin C Based Glomerular Filtration Rate Formulae with 51Chromium-EDTA clearance in Patients with Decompensated Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S259-S259

2016

Volltextzugriff (PDF)

Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis

Hippokratia, 2020-01, Vol.24 (4), p.157-165

2020

Volltextzugriff (PDF)

P401 DISEASE PROGRESSION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS UNDER LONG-TERM TREATMENT WITH URSODEOXYCHOLIC ACID – A HISTOLOGY-BASED ANALYSIS

Journal of hepatology, 2014-04, Vol.60 (1), p.S201-S202

2014

Volltextzugriff (PDF)

P889 NEW NUCLEOS(T)IDE ANALOGUE MONOPROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2014-04, Vol.60 (1), p.S370-S371

2014

Volltextzugriff (PDF)

P0079 : Nucleos(t)ide analogue prophylaxis after hepatitis B immunoglobulin withdrawal is safe and effective against hepatitis B and D recurrence after liver transplantation

Journal of hepatology, 2015-04, Vol.62, p.S322-S323

2015

Volltextzugriff (PDF)

145 THE CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS AMELIORATES RENAL FUNCTION AND PREVENTS HEPATOCELLULAR CARCINOMA WITHOUT ANY EPISODE OF REJECTION

Journal of hepatology, 2013-04, Vol.58, p.S65-S65

2013

Volltextzugriff (PDF)

480 ANTIVIRAL THERAPY CAN LEAD TO FIBROSIS REGRESSION IN ANTIHBE-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED IN CLINICAL PRACTICE

Journal of hepatology, 2012-04, Vol.56, p.S189-S189

2012

Volltextzugriff (PDF)

577 ASSESSMENT OF ADRENAL FUNCTION IN PATIENTS WITH STABLE DECOMPENSATED CIRRHOSIS USING SALIVARY AND TOTAL SERUM CORTISOL

Journal of hepatology, 2013-04, Vol.58, p.S236-S237

2013

Volltextzugriff (PDF)

1021 CARDIAC DIASTOLIC DYSFUNCTION IS ASSOCIATED WITH IMPAIRED NATRIURESIS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ASCITES

Journal of hepatology, 2013-04, Vol.58, p.S420-S420

2013

Volltextzugriff (PDF)

669 RANDOM SPOT URINE SODIUM/POTASIUM RATIO IS ASSOCIATED WITH RENAL DYSFUNCTION AND OUTCOME IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ASCITES

Journal of hepatology, 2012-04, Vol.56, p.S265-S265

2012

Volltextzugriff (PDF)

618 GLOMERULAR FILTRATION RATE PERFORMS BETTER COMPARED TO MELD SCORE IN PATIENTS WITH DECOMPENSATED CIRRHOSIS

Journal of hepatology, 2012-04, Vol.56, p.S245-S245

2012

Volltextzugriff (PDF)

P861 Frequency and Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Diseases

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i983-i985

2023

Volltextzugriff (PDF)

P844 Frequency of Extraintestinal Manifestations in vedolizumab versus anti-TNF Treated Patients with Inflammatory Bowel Diseases

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i969-i970

2023

Volltextzugriff (PDF)

P846 Epidemiological and Clinical Characteristics of Inflammatory Bowel Diseases in Patients from Greece

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i971-i972

2023

Volltextzugriff (PDF)

470 DOES HEPATIC STEATOSIS OR OBESITY INFLUENCE THE EFFICACY OF PEGYLATED INTERFERONS DIFFERENTLY?

Journal of hepatology, 2011-03, Vol.54, p.S192-S192

2011

Volltextzugriff (PDF)

The clinical presentation of Von Meyenburg complexes

Hippokratia, 2011-01, Vol.15 (2), p.170-173

2011

Volltextzugriff (PDF)

511 HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS

Journal of hepatology, 2012-04, Vol.56, p.S201-S202

2012

Volltextzugriff (PDF)

350 TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN PATIENTS WITH CHRONIC HEPATITIS B IN EVERYDAY CLINICAL PRACTICE

Journal of hepatology, 2011-03, Vol.54, p.S140-S141

2011

Volltextzugriff (PDF)

331 INCREASED SERUM LEVELS OF TNF-LIKE CYTOKINE 1A (TL1A) AND ITS DECOY RECEPTOR 3 (DCR3) PREDICT ABSENCE OF FIBROSIS IN CHRONIC HEPATITIS B VIRUS INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S133-S133

2011

Volltextzugriff (PDF)

714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT

Journal of hepatology, 2011-03, Vol.54, p.S286-S287

2011

Volltextzugriff (PDF)

P628 Risk Factors Associated with Extraintestinal Manifestations in Patients with Inflammatory Bowel Diseases

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S566-S566

2021

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(45)
Berichte
(2)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Prevalence of hepatitis E in liver transplant recipients in Greece

Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease

Urine Albumin-To-Creatinine Ratio is Associated with the Severity of Liver Disease, Renal Function and Survival in Patients with Decompensated Cirrhosis

Comparison of Creatinine and Cystatin C Based Glomerular Filtration Rate Formulae with 51Chromium-EDTA clearance in Patients with Decompensated Cirrhosis

Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis

Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort study

P401 DISEASE PROGRESSION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS UNDER LONG-TERM TREATMENT WITH URSODEOXYCHOLIC ACID – A HISTOLOGY-BASED ANALYSIS

P889 NEW NUCLEOS(T)IDE ANALOGUE MONOPROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION

P0079 : Nucleos(t)ide analogue prophylaxis after hepatitis B immunoglobulin withdrawal is safe and effective against hepatitis B and D recurrence after liver transplantation

145 THE CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS AMELIORATES RENAL FUNCTION AND PREVENTS HEPATOCELLULAR CARCINOMA WITHOUT ANY EPISODE OF REJECTION

480 ANTIVIRAL THERAPY CAN LEAD TO FIBROSIS REGRESSION IN ANTIHBE-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED IN CLINICAL PRACTICE

577 ASSESSMENT OF ADRENAL FUNCTION IN PATIENTS WITH STABLE DECOMPENSATED CIRRHOSIS USING SALIVARY AND TOTAL SERUM CORTISOL

1021 CARDIAC DIASTOLIC DYSFUNCTION IS ASSOCIATED WITH IMPAIRED NATRIURESIS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ASCITES

669 RANDOM SPOT URINE SODIUM/POTASIUM RATIO IS ASSOCIATED WITH RENAL DYSFUNCTION AND OUTCOME IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ASCITES

618 GLOMERULAR FILTRATION RATE PERFORMS BETTER COMPARED TO MELD SCORE IN PATIENTS WITH DECOMPENSATED CIRRHOSIS

P861 Frequency and Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Diseases

P844 Frequency of Extraintestinal Manifestations in vedolizumab versus anti-TNF Treated Patients with Inflammatory Bowel Diseases

P846 Epidemiological and Clinical Characteristics of Inflammatory Bowel Diseases in Patients from Greece

470 DOES HEPATIC STEATOSIS OR OBESITY INFLUENCE THE EFFICACY OF PEGYLATED INTERFERONS DIFFERENTLY?

The clinical presentation of Von Meyenburg complexes

511 HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS

350 TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN PATIENTS WITH CHRONIC HEPATITIS B IN EVERYDAY CLINICAL PRACTICE

331 INCREASED SERUM LEVELS OF TNF-LIKE CYTOKINE 1A (TL1A) AND ITS DECOY RECEPTOR 3 (DCR3) PREDICT ABSENCE OF FIBROSIS IN CHRONIC HEPATITIS B VIRUS INFECTION

714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT

P628 Risk Factors Associated with Extraintestinal Manifestations in Patients with Inflammatory Bowel Diseases

Aktive Filter

Suchergebnisse filtern